Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Apitoria Pharma Private Limited is a healthcare company focused on pharmaceutical research and development. It specializes in creating innovative drug formulations and therapeutic solutions, addressing critical health challenges across various therapeutic areas, including oncology and neurology, while ensuring high-quality standards and regulatory compliance.
Apitoria Pharma Private Limited, is an unlisted private company incorporated on 20 December, 2017. It is classified as a private limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 100.00 cr and the total paid-up capital is INR 99.00 cr.
Read more
** All rupee values in INR crores. Based on March 2025 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Nithyananda Reddy Kambam
Shareholder
|
01284195 | 4 years |
| Director | Santhanam Subramanian | 03516515 | 4 years |
| Director | Santanu Mukherjee | 07716452 | 1 years |
| Director | Mylandlahalli Rammohan Ashwini | 10568862 | 3 years |
| Director | Satakarni Makkapati | 09377266 | 3 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | - | - | - | 5,688.8 | 6,808.2 |
| Operating profit | - | - | - | 503.6 | 603.7 |
| Net profit | - | - | - | 189.1 | 251.2 |
| Gross margin | - | - | - | 40.9 | 36.1 |
| Operating margin | - | - | - | 8.8 | 8.9 |
| Net margin | - | - | - | 3.3 | 3.7 |
| Networth | - | - | - | 149.5 | 399.5 |
| Borrowings | - | - | - | 4,307.8 | 4,261.6 |
| Assets | - | - | - | 6,193.8 | 6,032.9 |
| Debt to equity | 0.0 | 0.0 | 0.0 | 28.8 | 10.7 |
| Current ratio | 57.6 | 60.8 | 55.4 | 2.5 | 2.2 |
| ROE | -5.8 | -10.4 | -9.5 | 126.5 | 62.9 |
| Days payable | - | - | - | 132.0 | 81.0 |
| WC days | - | - | - | 183.0 | 135.0 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.1 | 0.1 | 0.1 | 99.0 | 99.0 |
| Reserves | - | - | - | 50.5 | 300.5 |
| Borrowings + | - | - | - | 4,307.8 | 4,261.6 |
| Long term borrowings | - | - | - | 3,925.9 | 3,350.0 |
| Short term borrowings | - | - | - | 381.9 | 911.6 |
| Trade payables + | - | - | - | 1,218.4 | 966.8 |
| Days payable | - | - | - | 132.0 | 81.0 |
| Other liabilities + | - | - | - | 518.1 | 405.0 |
| Other non-current liabilities | - | - | - | 277.8 | 269.3 |
| Other current liabilities | - | - | - | 240.3 | 135.7 |
| Total liabilities | - | - | - | 6,193.8 | 6,032.9 |
| Fixed Assets + | - | - | - | 1,440.0 | 1,436.9 |
| Tangible assets | - | - | - | 1,285.2 | 1,394.8 |
| CWIP | - | - | - | 154.9 | 42.0 |
| Intangible assets | - | - | - | - | - |
| LT loans and advances | - | - | - | 2.2 | 2.6 |
| Other non-current assets | - | - | - | 52.5 | 54.6 |
| Current assets + | - | - | - | 4,699.0 | 4,538.9 |
| Inventories | - | - | - | 2,197.2 | 2,034.5 |
| Trade receivables | - | - | - | 1,970.9 | 2,131.8 |
| Cash and cash equivalents | - | - | - | 65.7 | 37.5 |
| ST loans and advances | - | - | - | 4.0 | 4.2 |
| Other current assets | - | - | - | 461.1 | 331.0 |
| Total assets | - | - | - | 6,193.8 | 6,032.9 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales + | - | - | - | 5,688.8 | 6,808.2 |
| Sales growth % | None | None | None | None | 19.68 |
| Expenses + | - | - | - | 5,438.1 | 6,475.0 |
| Cost of goods | - | - | - | 3,360.7 | 4,350.3 |
| Employee cost | - | - | - | 820.1 | 870.0 |
| Other costs | - | - | - | 1,004.4 | 984.2 |
| Operating profit + | - | - | - | 503.6 | 603.7 |
| Operating margin % | - | - | - | 8.8 | 8.9 |
| Other income | - | - | - | 3.6 | 3.4 |
| Interest | - | - | - | 56.3 | 60.8 |
| Depreciation | - | - | - | 196.6 | 209.6 |
| Exceptional items | - | - | - | - | - |
| Profit before tax | - | - | - | 254.3 | 336.6 |
| Tax | - | - | - | 65.2 | 85.4 |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | - | - | - | 189.1 | 251.2 |
| Net margin % | - | - | - | 3.3 | 3.7 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 0.0 | 0.0 | 0.0 | 28.8 | 10.7 |
| Net Debt/Equity | 0.0 | 0.0 | 0.0 | 28.4 | 10.6 |
| Total Debt/Assets | 0.0 | 0.0 | 0.0 | 0.7 | 0.7 |
| Total Assets/Equity | 1.0 | 1.0 | 1.0 | 41.4 | 15.1 |
| Liquidity + | |||||
| Current Ratio | 57.6 | 60.8 | 55.4 | 2.5 | 2.2 |
| Quick Ratio | 57.6 | 60.8 | 55.4 | 1.4 | 1.2 |
| Interest Coverage | - | - | - | 8.9 | 9.9 |
| Performance | |||||
| Gross Margin | - | - | - | 40.9 | 36.1 |
| Operating Margin | - | - | - | 8.8 | 8.9 |
| Net Margin | - | - | - | 3.3 | 3.7 |
| Return + | |||||
| Return on Equity | -5.8 | -10.4 | -9.5 | 126.5 | 62.9 |
| Pre-tax ROCE | -5.9 | -10.6 | -9.7 | 7.1 | 9.9 |
| Return on Assets | -5.8 | -10.3 | -9.3 | 3.0 | 4.2 |
| Pre-tax ROIC | -5.8 | -10.4 | -9.5 | 7.0 | 8.5 |
| Efficiency + | |||||
| Days Payable | - | - | - | 132.0 | 81.0 |
| Days Inventory | - | - | - | 239.0 | 171.0 |
| Days Receivable | 0.0 | 0.0 | 0.0 | 126.0 | 114.0 |
| Fixed Asset Turnover | - | - | - | 4.0 | 4.7 |
| Total Asset Turnover | 0.0 | 0.0 | 0.0 | 0.9 | 1.1 |
| Working Capital | |||||
| Cash Conversion Cycle | 0.0 | 0.0 | 0.0 | 233.0 | 204.0 |
| Working Capital Days | - | - | - | 183.0 | 135.0 |
As per information available, the company has no registered charges.
Read more
The incorporation date of APITORIA PHARMA PRIVATE LIMITED is 20 December, 2017
The authorized share capital of APITORIA PHARMA PRIVATE LIMITED is INR ₹ 100.0 Cr.
The paid-up capital of APITORIA PHARMA PRIVATE LIMITED is INR ₹ 99.0 Cr.
The registered address of APITORIA PHARMA PRIVATE LIMITED is Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak tha Hyderabad Telangana - 500032
The CIN number of APITORIA PHARMA PRIVATE LIMITED is U24298TG2017PTC121342.